Tarsons Products Limited (NSE:TARSONS)
India · Delayed Price · Currency is INR 196.00
-3.64 (-1.82%)
Feb 19, 2026, 3:29 PM IST
Tarsons Products Revenue
Tarsons Products had revenue of 1.08B INR in the quarter ending December 31, 2025, with 12.77% growth. This brings the company's revenue in the last twelve months to 4.14B, up 7.48% year-over-year. In the fiscal year ending March 31, 2025, Tarsons Products had annual revenue of 3.92B with 32.40% growth.
Revenue (ttm)
4.14B
Revenue Growth
+7.48%
P/S Ratio
2.56
Revenue / Employee
4.57M
Employees
906
Market Cap
10.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.92B | 960.20M | 32.40% |
| Mar 31, 2024 | 2.96B | 131.46M | 4.64% |
| Mar 31, 2023 | 2.83B | -175.46M | -5.83% |
| Mar 31, 2022 | 3.01B | 694.77M | 30.04% |
| Mar 31, 2021 | 2.31B | 563.32M | 32.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Sastasundar Ventures | 12.78B |
| Ind-Swift Laboratories | 5.94B |
| GPT Healthcare | 4.48B |
| Beta Drugs | 3.85B |